Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry

Journal of Nuclear Medicine · Published 2026-05-21 · DOI 10.2967/jnumed.125.271770

Free full text

Authors (38)

Nika Guberina, Madeleine J. Karpinski, Maja Guberina, Sebastian Hoberück, Matthias Miederer, Tobias Hölscher, Isabel Rauscher, Matthias Eiber, Andrew Nguyen, Lela Theus, Matteo Bauckneht, Helen Scholtissek, Kambiz Rahbar, Jonathan Miksch, Daniele Antonio Pizzuto, Karolien Goffin, Caner Civan, Shima F. Reinwand, Andreas Stang, Jens Kleesiek, Anja Merkel-Jens, Lale Umutlu, Alfonso Santangelo, Timo F. W. Soeterik, Stephan Beintner-Skawran, Andrej Vondrak, Anders Bjartell, Laura Evangelista, Sazan Rasul, Marcin Miszczyk, Adrien Holzgreve, Gabriel T. Sheikh, Andrea Di Giorgio, Andrea Farolfi, Ken Herrmann, Boris Hadaschik, Wolfgang P. Fendler, Martin Stuschke

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Guberina, N., Karpinski, M., Guberina, M., et al. (2026). Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE Registry. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.125.271770

Related articles